Cromwell Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Cromwell Holdings's PFE Position: Q3 2026 in Review
Cromwell Holdings reduced its Pfizer (PFE) stake by 10% in Q3 2026, selling an estimated $52K and leaving 16,661 shares worth $475K. The position accounts for 0.21% of the portfolio, ranked #83.
Cromwell Holdings first reported a position in PFE in Q2 2024 and has held it in 10 quarters since. The position peaked at $519K in Q1 2026. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Cromwell Holdings held 16,661 shares of Pfizer worth $475K as of Q3 2026.
- Cromwell Holdings sold 1,954 Pfizer shares in Q3 2026, an estimated $52K.
- Pfizer made up 0.21% of Cromwell Holdings's portfolio in Q3 2026, its #83 holding.
- Cromwell Holdings first reported a position in Pfizer in Q2 2024 and has held it in 10 quarters since.
- Cromwell Holdings's Pfizer position peaked at $519K in Q1 2026.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.